What Paradigm Health does
Paradigm Health builds AI-powered infrastructure that lets hospitals and health systems run clinical trials as part of routine patient care. The company operates what it describes as the largest oncology research network in the U.S., spanning 45 states and 166 provider organizations. It acquired Flatiron Health's clinical research business and partnered with the FDA to modernize trial-data review. Paradigm was incubated by ARCH Venture Partners and General Catalyst starting in 2021 and launched from stealth with a $203M Series A in January 2023.
Paradigm Health is a healthcare tool on Falcoscan. AI-native platform making clinical trials part of routine patient care. Falcoscan rates Paradigm Health with an Opportunity score of 86/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Paradigm Health is founded in 2021, currently at Series_b stage. Pricing: Paid.